Literature DB >> 235634

Urinary excretion of morphine and its metabolites in morphine-dependent subjects.

S Y Yeh.   

Abstract

Morphine, morphine glucuronide, morphine ethereal sulfate, normorphine and total normorphine in three consecutive 24-hour urines of four morphine-dependent subjects receiving morphine sulfate 60 mg s.c. q.i.d. have been determined with thin-layer chromatography and gas-liquid chromatography. With thin-layer chromatography the mean daily excretion of free morphine was 10% of the administered dose; morphine glucuronide, 65%; total (free and acid hydrolyzable conjugate) morphine 85%; and total normorphine, 3.5%. With gas-liquid chromatography, the percentage excretion for free morphine was 10%; total morphine, 74%; free normorphine, 1%; and total normorphine, 4%. The excretion of total drug was linearly related to the volume of the daily urine output.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235634

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

Review 1.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

Review 2.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

3.  Intubation and other experiences in cardiac surgery: the consumer's views.

Authors:  B Paiement; M Boulanger; C W Jones; M Roy
Journal:  Can Anaesth Soc J       Date:  1979-05

Review 4.  Pharmacokinetics in intravenous anaesthetic practice.

Authors:  P Duvaldestin
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

5.  Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation.

Authors:  J Säwe; L Kager; J O Svensson Eng; A Rane
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

6.  Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.

Authors:  J Hasselström; J Säwe
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

7.  Measurement and control of postoperative pain.

Authors:  J Nayman
Journal:  Ann R Coll Surg Engl       Date:  1979-11       Impact factor: 1.891

8.  Renal failure does not impair the metabolism of morphine.

Authors:  D F Woolner; D Winter; T J Frendin; E J Begg; K L Lynn; G J Wright
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

9.  Morphine sulphation in children.

Authors:  I Choonara; Y Ekbom; B Lindström; A Rane
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

10.  Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence.

Authors:  J Säwe; J O Svensson; A Rane
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.